Top Markets
Coin of the day
Australian Clinical Labs Limited Australian Clinical Labs Limited

Australian Clinical Labs Limited

ACL
株式のランク #15163
Australian Clinical Labs Limited operates across Australia, delivering a... Australian Clinical Labs Limited operates across Australia, delivering a diverse range of diagnostic pathology services. The company's extensive portfolio encompasses standard examinations alongside advanced molecular genetics, including Harmony NIPT and initial trimester screenings, as well as genetic carrier screening. Furthermore, it provides detailed analyses in chemical, tissue (histopathology), and cellular (cytopathology) pathology; specialized tests for hematology, allergies, and immunology; and comprehensive serology and microbiology services. ACL also performs infectious molecular testing, cardiac diagnostic assessments, functional pathology, veterinary pathology, and commercial drug and alcohol screening. These essential services are supplied to both private and public hospitals throughout the nation. The company was founded in 2020 and maintains its primary operational base in Clayton, Australia.
株価
$1.98
時価総額
$368.99M
変化(1日)
0.90%
変化(1年)
11.38%
AU
取引 Australian Clinical Labs Limited (ACL)

カテゴリー

Australian Clinical Labs Limited(ACL)の株式分割履歴
Australian Clinical Labs Limited株(シンボル:ACL)は合計で0回の株式分割を実施しました。
最新の株式分割はSep 01, 2026に行われました。
Sep 01, 2026より前に購入されたACL株は、現在0ACL株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US